Emerging Trends in Infectious Disease Prevention and Control

Dear Colleagues,

Infectious diseases have posed a significant threat to human health throughout history, leading to widespread morbidity and mortality. From the advent of antibiotics and vaccines to modern diagnostic technologies, the field of infectious disease prevention and control has undergone transformative changes. However, the emergence of new pathogens, the increasing threat of antimicrobial resistance, and the challenges of global interconnectedness continue to complicate efforts. The COVID-19 pandemic further illuminated the complexities of managing infectious diseases, emphasizing the critical need for adaptive, cutting-edge strategies in the face of evolving threats.

This Special Issue, entitled “Emerging Trends in Infectious Disease Prevention and Control”, aims to highlight the latest advancements in the prevention, diagnosis, treatment, and management of infectious diseases. Areas of focus include, but are not limited to, the following:

• Advancements in rapid pathogen detection;
• The role of molecular diagnosis in infectious disease control;
• Continuous antibiotic resistance surveillance and stewardship;
• Novel microbiome findings;
• Novel biochemical antimicrobials and their mechanisms of action;
• Development of alternative therapies in antimicrobial resistance;
• Antiviral resistance and strategies for developing novel therapeutics;
• Next-generation vaccine development and deployment strategies;
• mRNA technology and its expanding role in infectious disease prevention;
• Artificial intelligence in infectious disease prediction and management;
• Implementation of One Health approaches;
• Harnessing epidemiological data for real-time public health interventions;
• Telemedicine and remote monitoring in infectious disease management;
• Global health policy and frameworks for pandemic preparedness.

This Special Issue highlights the importance of the future development of novel vaccine platforms, such as mRNA and viral vector vaccines, the use of phage therapy, possible alternative therapies, advancements in genomic surveillance and pathogen genomics, the role of artificial intelligence, machine learning, and digital health technologies, new approaches to antimicrobial stewardship and the development of alternative therapies, and the practical application of One Health approaches in medicine.

We welcome the submission of original research articles, reviews, narrative reviews, scoping reviews, systematic reviews and meta-analyses that address the latest trends in infectious disease prevention and control within medicine, as previously described.

Dr. Iulia-Cristina Bagiu
Dr. Florin George Horhat
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• antimicrobial resistance
• antimicrobial stewardship
• novel identification
• molecular diagnosis
• vaccines
• artificial intelligence
• epidemiology
• healthcare policies
• alternative therapy